34. Sevanian, A.; Davies K. J. A.; Hochstein, P. Serum mate as an
antioxidant for ascorbic acid. Am. J. Clin. Nutr. 5431298-1348;
1991. 40.
35. Shenk, J. 0.; Miller, E.; Gaddis, R.; Adams, R. N. Homeostatic
control of ascorbate concentrations in CNS extracellular fluid.
Brain Res. 253:353-356; 1982.
36. Sian, J.; Dexter, D. T.; Jenner, P.; Marsden, C. D. Decrease in 41.
nigral reduced glutathione levels in Parkinson's disease. Br. J.
Pharmacol. 104:273P; 1991.
37. Sofic, E.; Lange, K. W.; Jellinger, K.; Riederer, P. Reduced
and oxidized glutathione in the substantia nigra of patients with 42.
Parkinson's disease. Neurosci. Lett. 142:128-130; 1992.
38. Srivastava, R.; Brouillet, E.; Beal, N. F.; Storey, E.; Hyman B.
T. Blockade of I-methyl-4-phenylpyridinium ion (MPP+) nigral
toxicity in the rat by prior decortication or MK-801 treatment. A 43.
stereological estimate of neuronal loss. Neurobiol. Aging 14:295- 301; 1993.
Turski, L.; Bressler, K.; Retting, K. J.; Loschmann, P. A.;
Wachtel, H. Protection of substantia nigra from MPP+ neuro-
